Endocrinology, Diabetes and Metabolism

4/24/19

Pioneering research conducted and advanced by Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, played a key role in the European Commission’s decision to approve dapagliflozin for patients with Type 1 diabetes.

1/16/19

The Clinical and Translational Science Institute (CTSI) has recognized two Jacobs School of Medicine and Biomedical Sciences faculty members for their clinical research work.

11/16/18

Twenty faculty members with a variety of clinical and research experience — representing nine medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences during the past several months.

10/31/18

Paresh Dandona, MD, PhD — who did the first pilot studies on how drugs developed for Type 2 diabetes patients might benefit adults with Type 1 diabetes — is launching a major, interventional study with 114 patients in Buffalo and Glasgow, Scotland.

8/16/18

Twelve projects and their researchers were recognized as best in their respective categories during the Department of Medicine’s sixth annual Research Day.

7/30/18

Research led by Paresh Dandona, MD, PhD, has shown that adding liraglutide to insulin treatment for patients with Type 1 diabetes provides health benefits.